UPDATE : Wednesday, January 22, 2020
상단여백
JW Bioscience to market JEOL's biochemical analysis equipment by Lee Han-soo 2020-01-14 16:21
After spotting mental problem, 30% puts off treatment for over 1 year by Kwak Sung-sun 2020-01-14 15:42
‘Hyperhidrosis can increase risk of cardiovascular diseases’ by Lee Han-soo 2020-01-14 15:28
Will Steglatro prove SGLT-2 inhibitor’s cardiovascular benefits? by Kim Yun-mi 2020-01-14 15:28
AMC researchers develop more accurate method to detect pulmonary tuberculosis by Lee Han-soo 2020-01-14 14:08
라인
[News Focus] Korean firms boast healthcare tech power at CES by Jeong Sae-im 2020-01-14 11:45
Genexine becomes largest shareholder of GenNBio by Lee Han-soo 2020-01-14 11:11
Daewoong, A2A to develop AI-based anticancer treatment by Lee Han-soo 2020-01-14 10:35
‘Drinking milk daily cuts breast cancer risk considerably’ by Shim Hyun-tai 2020-01-14 07:44
GSK shows meaningful response rate for treatment of multiple myeloma by Lee Han-soo 2020-01-13 17:48
라인
Korea seeks to lead international standards for medical 3D printing by Kwak Sung-sun 2020-01-13 16:26
Zejula widens indication as monotherapy for ovarian cancer by Kim Yun-mi 2020-01-13 16:25
Mysterious pneumonia case unrelated to China outbreaks by Kwak Sung-sun 2020-01-13 16:24
Mundipharma to commercialize Samsung Bioepis’ biosimilar in Hong Kong, Taiwan by Lee Han-soo 2020-01-13 16:23
Vivozon positive of Opiranserin’s efficacy despite failures to meet primary endpoint by Lee Han-soo 2020-01-13 16:22
라인
[CES 2020] Digital therapeutics to change the standard of care by Lee Han-soo 2020-01-13 14:06
Lilly secures atopic dermatitis drug through Dermira acquisition by Kim Yun-mi 2020-01-13 14:05
[CES 2020] ‘5G to accelerate innovation in healthcare’ by Song Soo-youn 2020-01-10 17:14
Korea to invest ₩420 billion in new drugs, medical devices, brain research by Kwak Sung-sun 2020-01-10 14:24
Latecomer Bavencio improves overall survival in bladder cancer trial by Kim Yun-mi 2020-01-10 14:23
여백
여백
여백
Back to Top